Biodesix, Inc. BDSX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$31.96M+9.4% | -$35.27M+10.8% | -$39.54M+3.8% | -$41.08M-1.6% | -$40.42M+5.9% | ||
| $5.63M-0.8% | $5.67M-1.1% | $5.73M-1.5% | $5.82M+0.4% | $5.79M+0.3% | ||
| $4.28M+3.5% | $4.14M-4.4% | $4.33M-9.6% | $4.79M-3.6% | $4.97M-25.1% | ||
| $103K-42.8% | $180K-66.9% | $543K-30.0% | $776K-9.7% | $859K-3.2% | ||
| —— | —— | $5.14M— | —— | —— | ||
| $1.45M-21.8% | $1.86M-27.9% | $2.58M— | —— | —— | ||
| $126K-3.1% | $130K+17.1% | $111K+318% | -$51K+51.4% | -$105K-54.4% | ||
| —— | —— | —— | —— | —— | ||
| $39K-63.6% | $107K-48.8% | $209K+3.5% | $202K-16.9% | $243K+2.1% | ||
| -$1.11M-40.9% | -$789K-78.9% | -$441K-145% | -$180K-217% | $154K-78.5% | ||
| $1.84M+613% | $258K— | —— | —— | —— | ||
| -$25.62M-6.5% | -$24.05M+14.6% | -$28.15M+6.0% | -$29.94M+28.6% | -$41.94M+13.8% | ||
| $266K+2.7% | $259K-74.4% | $1.01M-15.3% | $1.2M-61.1% | $3.07M-5.0% | ||
| -$410K-1.7% | -$403K+65.9% | -$1.18M+15.6% | -$1.4M+57.6% | -$3.3M+4.0% | ||
| $19K-9.5% | $21K-27.6% | $29K-23.7% | $38K-15.6% | $45K-11.8% | ||
| —— | —— | —— | —— | —— | ||
| -$777K+4.9% | -$817K-12.8% | -$724K-6.0% | -$683K-19.2% | -$573K-28.8% | ||
| $47K+56.7% | $30K-16.7% | $36K+5.9% | $34K-8.1% | $37K-15.9% | ||
| $33.22M+102% | $16.42M+11.6% | $14.71M+46.6% | $10.03M-80.5% | $51.54M-1.3% | ||
| —— | —— | —— | —— | $6.11M+15,772% | ||
| $6.64M+3.8% | $6.4M-12.0% | $7.27M-3.0% | $7.49M+8.2% | $6.93M-1.4% | ||
| $1.33M+1.8% | $1.3M+3.0% | $1.27M+24.5% | $1.02M-40.4% | $1.71M-30.7% | ||
| -$1.11M-40.9% | -$789K-78.9% | -$441K-145% | -$180K-217% | $154K-78.5% | ||
| $1.84M+613% | $258K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $103K-42.8% | $180K-66.9% | $543K-30.0% | $776K-9.7% | $859K-3.2% | ||
| $144K0.0% | $144K-15.8% | $171K-17.4% | $207K-11.5% | $234K+11.4% | ||
| —— | —— | —— | —— | —— | ||
| $47K+56.7% | $30K-16.7% | $36K+5.9% | $34K-8.1% | $37K-15.9% | ||
| —— | —— | —— | —— | $656K+5.0% | ||
| -$777K+4.9% | -$817K-12.8% | -$724K-6.0% | -$683K-19.2% | -$573K-28.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$1.11M-40.9% | -$789K-78.9% | -$441K-145% | -$180K-217% | $154K-78.5% | ||
| —— | $1.45M+34.9% | $1.07M+26.7% | $845K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $69.25K+889% | $7K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$25.8M-6.5% | -$24.22M+16.9% | -$29.16M+6.3% | -$31.13M+30.8% | -$45.01M+13.2% | ||
| -$25.8M-6.5% | -$24.22M+16.9% | -$29.16M+6.3% | -$31.13M+30.8% | -$45.01M+13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biodesix, Inc. generate?
- Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
- What is Biodesix, Inc.'s free cash flow?
- After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
- Where does Biodesix, Inc.'s cash flow data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
